Literature DB >> 26684608

Isavuconazole: a role for the newest broad-spectrum triazole.

Monica A Slavin1, Karin A Thursky2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26684608     DOI: 10.1016/S0140-6736(15)01218-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Necrotizing fungal gingivitis in a patient with Acute Myelogenous Leukemia: visible yet obscure.

Authors:  Prajwal Boddu; Pei-Ling Chen; Priyadharsini Nagarajan; Victor G Prieto; Alex Won; Mark Chambers; Steven Kornblau
Journal:  J Oral Maxillofac Surg Med Pathol       Date:  2017-09-12

Review 2.  Isavuconazole: A Review in Invasive Aspergillosis and Mucormycosis.

Authors:  Matt Shirley; Lesley J Scott
Journal:  Drugs       Date:  2016-11       Impact factor: 9.546

Review 3.  Role of isavuconazole in the treatment of invasive fungal infections.

Authors:  Dustin T Wilson; V Paul Dimondi; Steven W Johnson; Travis M Jones; Richard H Drew
Journal:  Ther Clin Risk Manag       Date:  2016-08-03       Impact factor: 2.423

Review 4.  Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations.

Authors:  Suganthini Krishnan Natesan; Pranatharthi H Chandrasekar
Journal:  Infect Drug Resist       Date:  2016-12-07       Impact factor: 4.003

5.  Late-onset isavuconazole-induced liver injury.

Authors:  Felix Bongomin; Isabel Rodriguez-Goncer; Carol Lorden; Akaninyene Otu; Rohit Bazaz
Journal:  Med Mycol Case Rep       Date:  2018-07-19

6.  Choosing the Right Antifungal Agent in ICU Patients.

Authors:  Jeanne Chatelon; Andrea Cortegiani; Emmanuelle Hammad; Nadim Cassir; Marc Leone
Journal:  Adv Ther       Date:  2019-10-15       Impact factor: 3.845

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.